oxide functions as an inhibitor of platelet adhesion under flow conditions Circulation 1992;85:2284–2290 46 Feletou M, Vanhoutte PM Endotheliumdependent hyperpolarization of canine coronary smooth muscle Br J Pharmacol 1988;93:515– 524 47 Chen G, Suzuki H, Weston AH Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels Br J Pharmacol 1988;95:1165–1174 48 Cohen RA, Vanhoutte PM Endotheliumdependent hyperpolarization: beyond nitric oxide and cyclic GMP Circulation 1995;92:3337–3349 49 Nelson MT, Quayle JM Physiological roles and properties of potassium channels in arterial smooth muscle Am J Physiol 1995;268:C799– C822 50 Jensen BS, Strobaek D, Christophersen P, et al Characterization of the cloned human intermediate-conductance Ca2+-activated k+ channel Am J Physiol 1998;275:C848–C856 51 Champion HC, Kadowitz PJ Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism Am J Physiol 1997;273:R414– R422 52 Hecker M, Bara AT, Bauersachs J, et al Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450derived arachidonic acid metabolite in mammals J Physiol 1994;481:407–414 53 Bauersachs J, Hecker M, Busse R Display of the characteristics of endothelium-derived hyperpolarizing factor by cytochrome P450derived arachidonic acid metabolite in the coronary microcirculation Br J Pharmacol 1994;113:1548–1553 54 Edwards G, Dora KA, Gardener MJ, et al K+ is an endothelium-derived hyperpolarizing factor in rat arteries Nature 1998;396:269–272 55 Taylor HJ, Chaytor AT, Evans WH, et al Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-a glycyrrhetinic acid Br J Pharmacol 1998;125:1–3 56 Matoba T, Shimokawa H, Kubota H, et al Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries Biochem Biophys Res Commun 2002;290:909–913 57 Chauhan SD, Nilsson H, Ahluwalia A, et al Release of C-type natriuretic peptide accounts for the biological activity of endotheliumderived hyperpolarizing factor Proc Natl Acad Sci USA 2003;100:1426–1431 58 Inokuchi K, Hirooka Y, Shimokawa H, et al Role of endothelium-derived hyperpolarizing factor in human forearm circulation Hypertension 2003;42:919–924 59 Yang Q, Yim AP, He GW The significance of endothelium-derived hyperpolarizing factor in the human circulation Curr Vasc Pharmacol 2007;5:85–92 60 Moncada S, Higgs EA, Vane JR Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation Lancet 1977;1:18–20 61 Yanagisawa M, Kurihara H, Kimura S, et al A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 1988;332:411–415 62 Saye JA, Singer HA, Peach MJ Role of endothelium in conversion of angiotensin I to angiotensin II in rabbit aorta Hypertension 1984;6:216–221 63 Arai H, Hori S, Aramori I, et al Cloning and expression of a cDNA encoding an endothelin receptor Nature 1990;348:730–732 64 Kiowski W, Lüscher TF, Linder L, et al